These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin. Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112 [TBL] [Abstract][Full Text] [Related]
6. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy. Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445 [TBL] [Abstract][Full Text] [Related]
8. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy. Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918 [TBL] [Abstract][Full Text] [Related]
9. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation. Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659 [TBL] [Abstract][Full Text] [Related]
10. Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience. Hayes CR; Keane D J Interv Card Electrophysiol; 2010 Mar; 27(2):117-22. PubMed ID: 20082132 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Wazni OM; Beheiry S; Fahmy T; Barrett C; Hao S; Patel D; Di Biase L; Martin DO; Kanj M; Arruda M; Cummings J; Schweikert R; Saliba W; Natale A Circulation; 2007 Nov; 116(22):2531-4. PubMed ID: 17998456 [TBL] [Abstract][Full Text] [Related]
13. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272 [TBL] [Abstract][Full Text] [Related]
14. Effect of anticoagulation on endothermal ablation of the great saphenous vein. Sharifi M; Mehdipour M; Bay C; Emrani F; Sharifi J J Vasc Surg; 2011 Jan; 53(1):147-9. PubMed ID: 20864301 [TBL] [Abstract][Full Text] [Related]
15. Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study. Hindricks G; Willems S; Kautzner J; De Chillou C; Wiedemann M; Schepel S; Piorkowski C; Risius T; Kottkamp H; J Cardiovasc Electrophysiol; 2009 Jul; 20(7):734-40. PubMed ID: 19298568 [TBL] [Abstract][Full Text] [Related]
16. Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin. Saad EB; Costa IP; Costa RE; Inácio LA; Slater C; Camiletti A; Moura Neto DG; Maldonado P; Camanho LE; Polanczky CA Arq Bras Cardiol; 2011 Oct; 97(4):289-96. PubMed ID: 21861038 [TBL] [Abstract][Full Text] [Related]
17. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis. Sarasin FP; Bounameaux H Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939 [TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis. Garton AB; Dudzinski J; Kowey PR J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104 [TBL] [Abstract][Full Text] [Related]
19. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Spyropoulos AC; Frost FJ; Hurley JS; Roberts M Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study. Goldstein JL; Larson LR; Yamashita BD; Fain JM; Schumock GT Am J Gastroenterol; 2001 Aug; 96(8):2360-6. PubMed ID: 11513175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]